Flen Health
Robin Nicholson is an experienced professional in commercial operations and marketing, currently serving as Head of Commercial Operations at Flen Health since March 2022. In this role, Robin collaborates with sales and marketing teams to develop strategies for Flen Health's EU divisions, while also engaging with R&D, Medical, and Clinical teams to enhance product pipelines. Previously, Robin held positions including International Marketing Director at Flen Health, UK Product Manager at Advancis Medical, and National Sales Manager at Flen Health. Robin’s extensive background includes various roles in market access, marketing management, and sales within the healthcare sector, supported by educational credentials in marketing and business management from institutions such as Sutton Coldfield College and Warwick Business School.
This person is not in any teams
This person is not in any offices
Flen Health
Flen Health Live the Life you love! Flen Health believes biotech innovations can help to build a securer life for you and for every human being. Flen Health wants to improve the quality of life of people suffering from skin disorders in a responsible way, by providing added value for patients, healthcare professionals, health authorities and the environment. Flen Health was established in 2000, building on the results of wound-treatment research performed by its managing director, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health developed and commercializes a number of innovative wound and skin healing solutions. Flen Health holds an ISO 13485 certificate that covers all its operations. Thanks to the success on the Belgian market, Flen Health initiated its international expansion. This resulted in the establishment of further affiliates across Europe (in The Netherlands, Luxembourg, UK & Germany), managed by over 100 motivated employees. Flen Health products are distributed in 25 countries all over the world. Current product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel®, Flamigel®RT, Flamirins® and extracalm®. Direct customers are mainly healthcare professionals: Flaminal® Hydro/Forte indicated for all kind of wound treatments and Flamigel® RT for skin damage caused by radiotherapy. Flen Health continues to expand its activities and invites motivated and dynamic people to join. Feel welcome to visit our website for more information: